41 related articles for article (PubMed ID: 8695876)
1. Treatment of chronic myelogenous leukemia (CML) with c-myb antisense oligodeoxynucleotides.
Gewirtz AM
Bone Marrow Transplant; 1994; 14 Suppl 3():S57-61. PubMed ID: 7697011
[No Abstract] [Full Text] [Related]
2. Antisense gene therapy trials underway in patients with CML.
Oncology (Williston Park); 1996 Sep; 10(9):1411. PubMed ID: 8882929
[No Abstract] [Full Text] [Related]
3. BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase.
de Fabritiis P; Petti MC; Montefusco E; De Propris MS; Sala R; Bellucci R; Mancini M; Lisci A; Bonetto F; Geiser T; Calabretta B; Mandelli F
Blood; 1998 May; 91(9):3156-62. PubMed ID: 9558370
[TBL] [Abstract][Full Text] [Related]
4. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
5. In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation.
de Fabritis P; Amadori S; Petti MC; Mancini M; Montefusco E; Picardi A; Geiser T; Campbell K; Calabretta B; Mandelli F
Leukemia; 1995 Apr; 9(4):662-4. PubMed ID: 7536864
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow purging with oligodeoxynucleotides.
Gewirtz AM; Luger SM; Stadtmauer E
Blood; 1996 Aug; 88(4):1517. PubMed ID: 8695876
[No Abstract] [Full Text] [Related]
7. Autologous transplantation therapy for chronic myelogenous leukemia.
Bhatia R; Verfaillie CM; Miller JS; McGlave PB
Blood; 1997 Apr; 89(8):2623-34. PubMed ID: 9108379
[No Abstract] [Full Text] [Related]
8. Antisense oligodeoxynucleotides as therapeutic agents for chronic myelogenous leukemia.
Nichols GL
Antisense Res Dev; 1995; 5(1):67-9. PubMed ID: 7613074
[No Abstract] [Full Text] [Related]
9. Specific bcr-abl-directed antisense nucleic acids and ribozymes: a tool for the treatment of chronic myelogenous leukemia?
Kronenwett R; Haas R
Recent Results Cancer Res; 1998; 144():127-38. PubMed ID: 9304714
[No Abstract] [Full Text] [Related]
10. Chronic myeloid leukaemia: a therapeutic challenge.
Mughal TI; Goldman JM
Ann Oncol; 1995 Sep; 6(7):637-44. PubMed ID: 8664183
[No Abstract] [Full Text] [Related]
11. Current approaches to hematopoietic stem-cell purging in chronic myeloid leukemia.
O'Brien SG; Goldman JM
J Clin Oncol; 1995 Mar; 13(3):541-6. PubMed ID: 7884413
[No Abstract] [Full Text] [Related]
12. BCR-ABL: an anti-apoptosis gene in chronic myelogenous leukemia.
Cotter TG
Leuk Lymphoma; 1995 Jul; 18(3-4):231-6. PubMed ID: 8535187
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
